Cite
HARVARD Citation
Shah, R. et al. (n.d.). S0826 Preoperative Vedolizumab, Ustekinumab, or Anti-Tumor Necrosis Factor Use Is Not Associated with Postoperative Complications in Crohn's Disease Patients Undergoing Ileocolic Resection. American journal of gastroenterology. pp. S424-S425. [Online].